Lucas Wong Selected Research

4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- one

1/2018	A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma.
5/2007	Phase I trial of imexon in patients with advanced malignancy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucas Wong Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 09/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2013
4	Colorectal Neoplasms (Colorectal Cancer) 04/2017 - 07/2008
2	Nausea 01/2020 - 12/2013
2	Adenocarcinoma 01/2018 - 11/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 09/2002
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 02/2002
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2014
2	Diarrhea 03/2015 - 07/2008
1	Chronic Pancreatitis 01/2022
1	Anticipatory Vomiting 01/2020
1	Vomiting 01/2020
1	Disease Progression 01/2017
1	Hyperplasia 01/2016
1	Cholangiocarcinoma 01/2016
1	Edema (Dropsy) 12/2013
1	Fatigue 12/2013
1	Leukemia 10/2012
1	Heart Diseases (Heart Disease) 10/2009
1	Carcinogenesis 05/2009
1	Dehydration (Water Stress) 07/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2007
1	Multiple Myeloma 12/2005
1	Tumor Lysis Syndrome 12/2005
1	Drug-Related Side Effects and Adverse Reactions 12/2005
1	Plasma Cell Leukemia 12/2005
1	Cytopenia 01/2005
1	Squamous Cell Carcinoma of Head and Neck 01/2005
1	Carcinoma (Carcinomatosis) 01/2005
1	Colonic Neoplasms (Colon Cancer) 11/2004
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 08/2004
1	Thrombosis (Thrombus) 09/2002
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2020 - 02/2002
3	Monoclonal AntibodiesIBA 12/2013 - 11/2004
2	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018 - 05/2007
2	Gemcitabine FDA Link 01/2018 - 12/2013
2	CaspasesIBA 12/2013 - 05/2009
2	beta CateninIBA 05/2009 - 08/2004
2	PPAR gammaIBA 05/2009 - 08/2004
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2022
1	Biological ProductsIBA 01/2022
1	ResveratrolIBA 01/2020
1	Leucovorin (Folinic Acid)FDA Link 04/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	olaratumabIBA 01/2017
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2016
1	Tolonium Chloride FDA Link 01/2016
1	Stem Cell FactorIBA 01/2016
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2016
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	Histidine DecarboxylaseIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2015
1	Calcium AluminosilicateIBA 03/2015
1	taxaneIBA 01/2014
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2014
1	Docetaxel (Taxotere)FDA Link 01/2014
1	Filgrastim (Neupogen)FDA Link 01/2014
1	tigatuzumabIBA 12/2013
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2013
1	Immunoglobulin G (IgG)IBA 10/2012
1	Bispecific AntibodiesIBA 10/2012
1	Single-Chain AntibodiesIBA 10/2012
1	PhosphatidylserinesIBA 11/2011
1	bavituximabIBA 11/2011
1	romidepsin (FK228)FDA Link 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009
1	Proteins (Proteins, Gene)FDA Link 05/2009
1	LigandsIBA 05/2009
1	Troglitazone (Rezulin)FDA Link 05/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2008
1	Capecitabine (Xeloda)FDA Link 07/2008
1	Bevacizumab (Avastin)FDA Link 07/2008
1	Glycogen Synthase Kinase 3IBA 10/2007
1	Bortezomib (Velcade)FDA Link 12/2005
1	Peptides (Polypeptides)IBA 12/2005
1	Proteasome InhibitorsIBA 12/2005
1	Immunotoxins (Immunotoxin)IBA 12/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2004
1	Glycogen Synthase Kinase 3 betaIBA 08/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2004
1	Glycogen Synthase KinasesIBA 08/2004
1	Carboplatin (JM8)FDA LinkGeneric 10/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2003
1	Ifosfamide FDA LinkGeneric 10/2003
1	PlatinumIBA 09/2002
1	Etoposide (VP 16)FDA LinkGeneric 09/2002
1	Cisplatin (Platino)FDA LinkGeneric 09/2002
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2002

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2021 - 09/2002
5	Therapeutics 01/2022 - 11/2004
1	Oral Administration 03/2015
1	Drug Tapering 07/2008
1	Neoadjuvant Therapy 01/2005
1	Radiotherapy 01/2005